Clinical Trial Update: A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A multicenter randomized double-blind placebo-controlled pilot study evaluating safety, pharmacodynamics, and efficacy of immunotherapeutic drug Mobilan (M-VM3)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Mobilan (M-VM3) (M-VM3)

Snippet

Sponsor: Panacela Labs LLC | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: UNKNOWN